Sales Ops Glossary · Process & Methodology
A Mutual Action Plan (MAP) is a shared, collaborative document that outlines the specific steps, task owners, and deadlines required for both the buyer and the seller to reach a signed contract and successful go-live. It replaces informal close date estimates with a concrete, agreed-upon timeline that both sides are accountable to.
A Mutual Action Plan is one of the most practical tools in enterprise sales for two reasons: it creates shared accountability for closing, and it surfaces deal risk early. When an AE puts a MAP in front of a prospect and the prospect engages with it — editing tasks, assigning owners, confirming timelines — that is a strong buying signal. When a prospect is unwilling to invest 20 minutes in completing a MAP, that is an equally important signal about how real the opportunity actually is.
MAPs also shift the dynamic in late-stage deals from 'the seller is chasing the buyer' to 'both parties are accountable to a shared plan.' AEs who use MAPs consistently report fewer end-of-quarter surprises because they have visibility into procurement timelines, legal review steps, and internal dependencies that are invisible without the MAP conversation. The document itself matters less than the process of building it together — that conversation reveals what the buyer actually knows and does not know about their own procurement path.
Deals without a MAP are invisible past verbal agreement. The AE knows the prospect said 'yes' but has no visibility into when legal review will start, who needs to sign off on budget, or whether the internal champion has actually begun the process of getting the deal approved. This creates the end-of-quarter pattern where committed deals slip because paper process was never mapped. According to Force Management, AEs who use MAPs consistently reduce close date slippage by 30-40% and increase their forecast accuracy significantly because they have real data, not optimistic estimates.
MAPs also increase win rates in competitive deals. A prospect working through a MAP with one vendor has invested time, built a relationship, and created a shared plan — switching to a competitor means starting that process over. The collaborative investment in a MAP creates switching costs that purely transactional selling does not. Enterprise AEs who introduce MAPs early in the process often find that competitors who show up late have less access and less internal support, because the MAP-running AE has already built the deeper relationship.
Evaluating process & methodology tools?
Browse software →An enterprise AE at a data security platform introduces the MAP immediately after a prospect's verbal intent to move forward. She sends a Google Doc or Notion page with two columns — 'Buyer Tasks' and 'Vendor Tasks' — and a shared timeline. In the first version, she pre-populates the vendor tasks and leaves buyer tasks blank with prompts: 'Legal review — owner: TBD, target start: TBD.' The act of filling in these blanks requires the prospect to think through their actual process, which surfaces dependencies she would not have discovered otherwise.
A common MAP discovery is procurement lead time. Many buyers do not know how long their own procurement process takes until they are asked to map it out. An AE who introduces a MAP in week four of a deal will hear 'I didn't realize our legal team has a three-week backlog right now' more often than expected. That discovery, made in week four, is recoverable. The same discovery made in week ten is a quarter slip. MAPs move this risk identification earlier in the cycle.
RevOps teams at mature SaaS companies build MAP templates into the CRM as an attachment or linked document field required at a specific deal stage. When a deal advances to 'Technical Evaluation Complete,' the AE must link a MAP with at least the go-live date, buyer-side legal owner, and contract execution target documented. This creates visibility for the VP of Sales and RevOps during forecast reviews without requiring the AE to manually brief everyone on deal status.
A MAP introduced at verbal close reveals paper process dependencies that should have been surfaced weeks earlier. By that point, the close date the AE committed is often already wrong. Introduce the MAP at the business case presentation stage — before mutual commitment, not after — to give yourself time to accelerate the steps that need it.
A MAP that only the seller maintains is a project tracker, not a closing tool. If the buyer is not updating their own tasks, they are not invested in the plan — and a plan neither party owns will not be followed. Shared edit access and explicit buyer task ownership are what make a MAP effective.
A completed MAP is a strong buying signal but not a signature. Prospects can complete a MAP and still choose a competitor or delay. The MAP is a qualification tool and a risk management tool — it surfaces dependencies and builds commitment — but it does not replace MEDDIC qualification or the fundamental work of building a strong business case.
In competitive deals, the vendor who gets a buyer Champion to co-own a MAP has a significant advantage — but sometimes the Champion is not senior enough to drive the MAP internally. AEs who rely on a junior contact to fill in procurement tasks and get exec approval will have incomplete MAPs that do not reflect reality. Involve the Economic Buyer in the MAP conversation, at minimum for timeline confirmation.
MAPs are often maintained in shared documents (Google Docs, Notion, Confluence) or purpose-built deal room tools. CRM-native MAPs allow visibility into deal progress without requiring a manager to ask. Sales enablement platforms can provide MAP templates standardized across the team so every AE starts from a consistent format.
The ideal moment to introduce a MAP is after the buyer has expressed clear intent to move forward — typically after a successful technical evaluation or a business case presentation — but before late-stage negotiation. Introducing too early (in early discovery) can feel presumptuous; introducing too late (at verbal close) misses the opportunity to surface paper process dependencies in time to address them. Most enterprise AEs aim for MAP introduction at the 60-70% mark of the deal cycle.
A project plan is created by the seller and delivered to the buyer as a one-way document. A MAP is co-created and co-owned by both parties. The collaborative creation is what makes a MAP effective — the process of building it together surfaces buyer-side dependencies, creates mutual accountability, and signals buyer investment in the deal. A project plan is informational; a MAP is a commitment device.
Detailed enough to be actionable, not so detailed that it becomes a burden to maintain. A good MAP has 10-20 tasks with owners and due dates, organized by buyer tasks and vendor tasks. It should include every task that could cause the deal to slip if missed — legal review, security questionnaire, budget approval, implementation scoping, contract execution — and not much else. Over-engineered MAPs with 50+ line items get abandoned because they take too long to maintain.
A MAP operationalizes the Decision Process element of MEDDIC. MEDDIC asks you to understand the steps required to go from verbal agreement to signed contract; a MAP is the living document that tracks those steps. The two work together: MEDDIC gives you the questions to ask about process, paper process, and procurement, and the MAP documents the answers and creates accountability. AEs using both MEDDIC and MAP together have substantially better forecast accuracy than those using either tool alone.
A prospect who will not engage with a MAP is worth examining carefully. It can mean the deal is not as serious as it appears, the Champion lacks the internal influence to drive a process, or the prospect is using your company for pricing leverage with an incumbent. It can also simply mean they have never seen a MAP before and find the ask unusual. Explain the value — 'this is how we make sure we meet your go-live date without surprises' — and try again with a lighter version. Persistent resistance is a qualification signal worth noting.